Beren Therapeutics
Recent Finacing
Hybrid
Recent Raise
$220M
Beren Therapeutics is a founder-led biotechnology company developing cyclodextrin-based therapeutics targeting defective intracellular cholesterol trafficking.
Highlights
Focus Areas
Biotechnology
Health Care
Medical
Therapeutics
Recent Investors
Financials
$220M
Total Raised
1
Funding round